Bio
We haven't found any bio for you yet.
Researcher Links
Loading links...
Publications by Type
Loading publications…
The last 5 uploaded publications
Dexamethasone, Rituximab and Cyclophosphamide with Bortezomib is a rapidly acting and highly efficient first-line treatment in Waldenström's Macroglobulinemia: Final analysis of ECWM-1 trial of the European Consortium for Waldenström's Macroglobulinemia (ECWM)
Pierre Morel, Christian Buske, Alexander Grunenberg, Efstathios Kastritis, Lydia Montes, Cécile Tomowiak, Roman Hájek, Andreas Viardot, Olivier Tournilhac, Thérèse Aurran, Florian Bouclet, Hacène Zerazhi, Bénédicte Hivert, Damien Roos‐Weil, Sophie de Guibert, Lena Brandefors, Ramón García‐Sánz, Maria Fátima das Graças Fernandes da Silva, Eva Kimby, Birgit Schmelzle, Dajana Kaszynski, Mélanie Verlay, Caroline Skrzypczak, Jens Dreyhaupt, Rainer Muche, Meletios A Dimopoulos (2025). Dexamethasone, Rituximab and Cyclophosphamide with Bortezomib is a rapidly acting and highly efficient first-line treatment in Waldenström's Macroglobulinemia: Final analysis of ECWM-1 trial of the European Consortium for Waldenström's Macroglobulinemia (ECWM). , 146(Supplement 1), DOI: https://doi.org/10.1182/blood-2025-223.
Article42 days agoReport of Consensus Panel 5 from the 12th International Workshop on Waldenstrom's Macroglobulinemia on the management of patients with intolerance or resistance to covalent BTK inhibitors
Jorge J. Castillo, Francesco Autore, Neil L. Berinstein, Andrew R. Branagan, Meletios A Dimopoulos, Carlos Fernández de Larrea, Simone Ferrero, Prashant Kapoor, Efstathios Kastritis, Jahanzaib Khwaja, Monique C. Minnema, Lugui Qiu, John F. Seymour, Josephine M. I. Vos, Christopher J. Patterson, Christian Buske, Jeffrey Matous, Steven P. Treon, M. Lia Palomba (2025). Report of Consensus Panel 5 from the 12th International Workshop on Waldenstrom's Macroglobulinemia on the management of patients with intolerance or resistance to covalent BTK inhibitors. , 62(2), DOI: https://doi.org/10.1053/j.seminhematol.2025.04.004.
Article42 days agoReport of Consensus Panel 3 from the 12th International Workshop on Waldenstrom's Macroglobulinemia on the management of patients with high-risk disease
Prashant Kapoor, Meletios A Dimopoulos, Stephen M. Ansell, Efstathios Kastritis, Ranjana H. Advani, Éric Durot, Pierre Morel, Charalampia Kyriakou, Roman Hájek, Daniela Drandi, Jithma P. Abeykoon, Signy Chow, Xinxin Cao, Christopher J. Patterson, Jeffrey Matous, Christian Buske, Steven P. Treon, Marie José Kersten (2025). Report of Consensus Panel 3 from the 12th International Workshop on Waldenstrom's Macroglobulinemia on the management of patients with high-risk disease. , 62(2), DOI: https://doi.org/10.1053/j.seminhematol.2025.04.001.
Article42 days agoData from Single-Agent Ibrutinib for Rituximab-Refractory Waldenström Macroglobulinemia: Final Analysis of the Substudy of the Phase III Innovate<sup>TM</sup> Trial
Judith Trotman, Christian Buske, Alessandra Tedeschi, Jeffrey Matous, D. Blair Macdonald, Constantine S. Tam, Olivier Tournilhac, Shuo Ma, Steven P. Treon, Albert Oriol, Jerry Ping, Eva M. Briso, Israel Arango‐Hisijara, Meletios A Dimopoulos (2024). Data from Single-Agent Ibrutinib for Rituximab-Refractory Waldenström Macroglobulinemia: Final Analysis of the Substudy of the Phase III Innovate<sup>TM</sup> Trial. , DOI: https://doi.org/10.1158/1078-0432.c.7524179.
Preprint42 days agoSupplementary Data from Single-Agent Ibrutinib for Rituximab-Refractory Waldenström Macroglobulinemia: Final Analysis of the Substudy of the Phase III Innovate<sup>TM</sup> Trial
Judith Trotman, Christian Buske, Alessandra Tedeschi, Jeffrey Matous, D. Blair Macdonald, Constantine S. Tam, Olivier Tournilhac, Shuo Ma, Steven P. Treon, Albert Oriol, Jerry Ping, Eva M. Briso, Israel Arango‐Hisijara, Meletios A Dimopoulos (2024). Supplementary Data from Single-Agent Ibrutinib for Rituximab-Refractory Waldenström Macroglobulinemia: Final Analysis of the Substudy of the Phase III Innovate<sup>TM</sup> Trial. , DOI: https://doi.org/10.1158/1078-0432.27609983.
Preprint42 days ago